Company Jubilant Pharmova Limited

Equities

JUBLPHARMA

INE700A01033

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:49 2024-04-26 am EDT 5-day change 1st Jan Change
680.7 INR +0.60% Intraday chart for Jubilant Pharmova Limited +2.26% +24.73%

Business Summary

Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company's segments include Pharmaceuticals, Contract Research and Development Services and Proprietary Novel Drugs. The Pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile injectables and non-sterile products through six manufacturing facilities in India, United States and Canada and a network of approximately 48 radio pharmacies in the United States. The Contract Research and Development Services segment provides drug discovery and development services as well as clinical data software and service solutions. The Proprietary Novel Drugs segment is a patient-focused biopharmaceutical business working to address unmet medical needs in oncology and autoimmune diseases.

Number of employees: 5,778

Sales per Business

INR in Million2022Weight2023Weight Delta
Radiopharma
40.6 %
- - 25,524 40.6 % -
Contract Research, and Development and Manufacturing Organisation
18.9 %
- - 11,847 18.9 % -
Contract Development and Manufacturing Organisation - Sterile Injecttables
18.4 %
- - 11,547 18.4 % -
Generics
12.1 %
- - 7,615 12.1 % -
Allergy Immunotherapy
9.6 %
- - 6,028 9.6 % -
Management Services
0.3 %
202 0.3 % 218 0.3 % +7.69%
Proprietary Novel Drugs
0.1 %
18 0.0 % 38 0.1 % +107.39%

Sales per region

INR in Million2022Weight2023Weight Delta
Americas and Europe
89.0 %
53,194 86.8 % 55,935 89.0 % +5.15%
Rest of the World
7.9 %
4,587 7.5 % 4,976 7.9 % +8.47%
India
3.0 %
3,394 5.5 % 1,907 3.0 % -43.83%

Managers

Managers TitleAgeSince
Chief Executive Officer 46 17-05-22
Chief Executive Officer 37 17-05-22
Director of Finance/CFO 52 21-03-31
Chairman 71 78-06-20
Chairman 67 81-12-31
Chief Tech/Sci/R&D Officer 46 22-05-03
Compliance Officer - 22-07-31
Public Communications Contact 63 09-05-31
Human Resources Officer - -
Corporate Officer/Principal - 21-10-24

Members of the board

Members of the board TitleAgeSince
Chairman 67 81-12-31
Chairman 71 78-06-20
Chief Executive Officer 46 17-05-22
Director/Board Member 72 17-05-22
Director/Board Member 69 17-05-22
Chief Executive Officer 37 17-05-22
Director/Board Member 69 23-03-06
Director of Finance/CFO 52 21-03-31
Director/Board Member 60 22-06-30
Director/Board Member 43 Oct. 31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 159,282,631 57,860,674 ( 36.33 %) 931,894 ( 0.5851 %) 36.33 %

Shareholders

NameEquities%Valuation
SPB Trustee Co. Pvt Ltd.
20.52 %
32,686,161 20.52 % 223 M ₹
HSB Trustee Co. Pvt Ltd.
19.00 %
30,257,475 19.00 % 206 M ₹
East Bridge Capital Management L.P.
7.496 %
11,939,881 7.496 % 81 M ₹
10,645,000 6.683 % 73 M ₹
Norges Bank Investment Management
3.955 %
6,300,201 3.955 % 43 M ₹
Miller Holdings Pte Ltd.
3.284 %
5,230,455 3.284 % 36 M ₹
Mav Management Advisors LLP
3.146 %
5,011,400 3.146 % 34 M ₹
Nikita Resources Pvt Ltd.
2.200 %
3,504,540 2.200 % 24 M ₹
quant Money Managers Ltd.
1.754 %
2,794,121 1.754 % 19 M ₹
Jubilant Energy Pvt Ltd.
1.328 %
2,116,000 1.328 % 14 M ₹

Holdings

NameEquities%Valuation
50,000 0.33% 697,821 $

Company contact information

Jubilant Pharmova Ltd.

1A, Sector-16A

201301, Noida

+91 12 0436 1000

http://www.jubilantpharmova.com
address Jubilant Pharmova Limited(JUBLPHARMA)

Group companies

NameCategory and Sector
Drugstore Chains
Pharmaceuticals: Major
Pharmaceuticals: Major
Jubilant Pharmaceuticals NV
Pharmaceuticals: Major
Miscellaneous Commercial Services
Pharmaceuticals: Major
TrialStat Solutions, Inc.
Jubilant Pharma Holdings, Inc.
  1. Stock Market
  2. Equities
  3. JUBLPHARMA Stock
  4. Company Jubilant Pharmova Limited